Han, Shulan
Ma, Wenyan
Jiang, Dawei
Sutherlin, Logan
Zhang, Jing
Lu, Yu
Huo, Nan
Chen, Zhao
Engle, Jonathan W.
Wang, Yanping
Xu, Xiaojie
Kang, Lei
Cai, Weibo
Wang, Lianyan
Funding for this research was provided by:
Beijing Natural Science Foundation (L202039)
Natural Science Foundation of Jilin Province (81973262)
National Science and Technology Major Project of China (2016ZX10004001-005)
National Natural Science Foundation of China (81972446, 81822037, 81871385)
Beijing Science Foundation for Distinguished Young Scholars (JQ19028)
PKU medicine-X Youth Program (PKU2021LCXQ023)
Open Funding Project of the State Key Laboratory of Biochemical Engineering (2020KF-01)
National Institutes of Health (P30CA014520)
Article History
Received: 22 August 2021
Accepted: 2 November 2021
First Online: 27 November 2021
Declarations
:
: Weibo Cai is scientific advisor, stockholder, and grantee of Focus-X Therapeutics, Inc. The other authors declare no competing financial interest.